Operational Costs for Cardiac and Breast Device Registries – extension

This measure will support patients with implanted high-risk cardiac and breast devices by extending operational funding for the Cardiac Devices Registry and the Australian Breast Device Registry for one year.

Page last updated: 09 May 2017

PDF Version: Operational Costs for Cardiac and Breast Device Registries – extension (PDF 102 KB)

Why is this important?

This measure will continue to drive improvements in clinical practice and patient outcomes for Australians with implanted cardiac or breast devices. The further year of funding will align with the completion of a national clinical quality registry policy and funding framework.

Who will benefit?

Patients with implanted high-risk cardiac and breast devices will benefit through improved devices, and better health care and outcomes.

Clinicians and medical device manufacturers will be supported in improving the safety and quality of their clinical practice and implantable cardiac and breast devices.

Driving improvements in clinical practice, cardiac and breast devices and health outcomes, and providing better value for money for all Australians, helps build a more sustainable health system.

How much will this cost?

This measure will cost $2.2 million in 2017–18.

In this section